Viking Therapeutics, Inc. ("Viking") , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that the ...
A multidisciplinary research team has discovered that liver alterations associated with metabolic dysfunction–associated ...
Type 2 diabetes (T2D) is a chronic metabolic disorder characterised by insulin resistance and impaired insulin secretion, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback